Leveljump Healthcare Corp. (JMPHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 8.26 Million CAD | 132.15% |
| 2022 | 3.55 Million CAD | 0.0% |
| 2021 | - CAD | -100.0% |
| 2020 | 86.58 Thousand CAD | 42.65% |
| 2019 | 60.69 Thousand CAD | 108.1% |
| 2018 | 29.16 Thousand CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 7.66 Million CAD | -2.94% |
| 2024 Q1 | 7.99 Million CAD | -2.08% |
| 2023 Q1 | 4.37 Million CAD | 23.01% |
| 2023 FY | 8.26 Million CAD | 132.15% |
| 2023 Q2 | 4.07 Million USD | -6.92% |
| 2023 Q3 | 3.94 Million USD | -3.29% |
| 2023 Q4 | 8.26 Million CAD | 109.65% |
| 2022 FY | 3.55 Million CAD | 0.0% |
| 2022 Q4 | 3.55 Million CAD | 19.39% |
| 2022 Q3 | 2.98 Million CAD | -3.14% |
| 2022 Q2 | 3.07 Million CAD | -2.78% |
| 2022 Q1 | 3.16 Million CAD | 0.0% |
| 2021 Q1 | 67.95 Thousand CAD | -21.51% |
| 2021 FY | - CAD | -100.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 Q3 | - CAD | -100.0% |
| 2021 Q2 | 10.59 Thousand CAD | -84.41% |
| 2020 FY | 86.58 Thousand CAD | 42.65% |
| 2020 Q3 | 77.03 Thousand CAD | -9.23% |
| 2020 Q2 | 84.86 Thousand CAD | 0.0% |
| 2020 Q1 | - CAD | -100.0% |
| 2020 Q4 | 86.58 Thousand CAD | 12.4% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q4 | 60.69 Thousand CAD | 0.0% |
| 2019 FY | 60.69 Thousand CAD | 108.1% |
| 2018 FY | 29.16 Thousand CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -137635.367% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -536.92% |
| Biocept, Inc. | 10.37 Million USD | 20.346% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 83.893% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 86.502% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -1412.678% |
| iMD Companies, Inc. | 1.1 Million USD | -648.788% |
| IDenta Corp. | 428.17 Thousand USD | -1830.076% |
| Interpace Biosciences, Inc. | 4.24 Million USD | -94.771% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -2872.706% |
| NovelStem International Corp. | 3.32 Million USD | -148.575% |
| Optigenex Inc. | 4.42 Million USD | -86.673% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -406.69% |
| Response Genetics, Inc | 4.91 Million USD | -68.038% |
| Rennova Health, Inc. | 359.19 Thousand USD | -2200.747% |
| RushNet, Inc. | 4.25 Million USD | -94.341% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -3218.258% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -935.032% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -1333.793% |
| Todos Medical Ltd. | 33 Million USD | 74.958% |